Annual Long Term Debt
$568.60 M
-$152.02 M-21.10%
December 31, 2023
Summary
- As of February 7, 2025, PCRX annual long term debt is $568.60 million, with the most recent change of -$152.02 million (-21.10%) on December 31, 2023.
- During the last 3 years, PCRX annual long term debt has risen by +$184.55 million (+48.05%).
- PCRX annual long term debt is now -23.81% below its all-time high of $746.26 million, reached on December 31, 2021.
Performance
PCRX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$433.77 M
-$205.68 M-32.17%
September 30, 2024
Summary
- As of February 7, 2025, PCRX quarterly long term debt is $433.77 million, with the most recent change of -$205.68 million (-32.17%) on September 30, 2024.
- Over the past year, PCRX quarterly long term debt has dropped by -$139.26 million (-24.30%).
- PCRX quarterly long term debt is now -45.74% below its all-time high of $799.45 million, reached on March 31, 2022.
Performance
PCRX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
PCRX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.1% | -24.3% |
| 3 y3 years | +48.0% | -45.7% |
| 5 y5 years | +95.7% | -45.7% |
PCRX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.8% | at low | -45.7% | at low |
| 5 y | 5-year | -23.8% | +63.9% | -45.7% | +25.0% |
| alltime | all time | -23.8% | +2967.4% | -45.7% | +7611.4% |
Pacira BioSciences Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $433.77 M(-32.2%) |
| Jun 2024 | - | $639.45 M(+13.4%) |
| Mar 2024 | - | $564.13 M(-0.8%) |
| Dec 2023 | $568.60 M(-21.1%) | $568.60 M(-0.8%) |
| Sep 2023 | - | $573.03 M(-3.2%) |
| Jun 2023 | - | $592.23 M(-2.2%) |
| Mar 2023 | - | $605.36 M(-16.0%) |
| Dec 2022 | $720.63 M(-3.4%) | $720.63 M(-7.5%) |
| Sep 2022 | - | $779.40 M(-1.3%) |
| Jun 2022 | - | $789.45 M(-1.3%) |
| Mar 2022 | - | $799.45 M(+7.1%) |
| Dec 2021 | $746.26 M(+94.3%) | $746.26 M(+89.9%) |
| Sep 2021 | - | $392.93 M(+0.8%) |
| Jun 2021 | - | $389.94 M(+0.8%) |
| Mar 2021 | - | $387.00 M(+0.8%) |
| Dec 2020 | $384.06 M(+10.7%) | $384.06 M(-27.4%) |
| Sep 2020 | - | $528.91 M(+36.3%) |
| Jun 2020 | - | $388.07 M(+10.8%) |
| Mar 2020 | - | $350.27 M(+0.9%) |
| Dec 2019 | $346.98 M | $346.98 M(+1.8%) |
| Sep 2019 | - | $340.96 M(+1.1%) |
| Jun 2019 | - | $337.23 M(+4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $323.65 M(+11.4%) |
| Dec 2018 | $290.59 M(+5.2%) | $290.59 M(+1.3%) |
| Sep 2018 | - | $286.89 M(+1.3%) |
| Jun 2018 | - | $283.26 M(+1.3%) |
| Mar 2018 | - | $279.69 M(+1.3%) |
| Dec 2017 | $276.17 M(+154.0%) | $276.17 M(+1.3%) |
| Sep 2017 | - | $272.72 M(+1.3%) |
| Jun 2017 | - | $269.33 M(+1.3%) |
| Mar 2017 | - | $265.99 M(+144.6%) |
| Dec 2016 | $108.74 M(+331.7%) | $108.74 M(+12.2%) |
| Jun 2013 | - | $96.89 M(+1.1%) |
| Mar 2013 | - | $95.86 M(+280.5%) |
| Dec 2012 | $25.19 M(+35.9%) | $25.19 M(-2.4%) |
| Sep 2012 | - | $25.81 M(+4.6%) |
| Jun 2012 | - | $24.67 M(-1.6%) |
| Mar 2012 | - | $25.07 M(+35.3%) |
| Dec 2011 | $18.54 M(-15.2%) | $18.54 M(-10.0%) |
| Sep 2011 | - | $20.60 M(-8.7%) |
| Jun 2011 | - | $22.58 M(+15.4%) |
| Mar 2011 | - | $19.57 M(-10.5%) |
| Dec 2010 | $21.87 M | $21.87 M(-59.4%) |
| Sep 2010 | - | $53.90 M(+858.3%) |
| Jun 2010 | - | $5.63 M |
FAQ
- What is Pacira BioSciences annual long term debt?
- What is the all time high annual long term debt for Pacira BioSciences?
- What is Pacira BioSciences annual long term debt year-on-year change?
- What is Pacira BioSciences quarterly long term debt?
- What is the all time high quarterly long term debt for Pacira BioSciences?
- What is Pacira BioSciences quarterly long term debt year-on-year change?
What is Pacira BioSciences annual long term debt?
The current annual long term debt of PCRX is $568.60 M
What is the all time high annual long term debt for Pacira BioSciences?
Pacira BioSciences all-time high annual long term debt is $746.26 M
What is Pacira BioSciences annual long term debt year-on-year change?
Over the past year, PCRX annual long term debt has changed by -$152.02 M (-21.10%)
What is Pacira BioSciences quarterly long term debt?
The current quarterly long term debt of PCRX is $433.77 M
What is the all time high quarterly long term debt for Pacira BioSciences?
Pacira BioSciences all-time high quarterly long term debt is $799.45 M
What is Pacira BioSciences quarterly long term debt year-on-year change?
Over the past year, PCRX quarterly long term debt has changed by -$139.26 M (-24.30%)